Roald Øien is professor of special education and developmental psychology at the Arctic University of Norway and adjunct assistant professor at the Yale Child Study Center.
Roald Øien
Professor
Arctic University of Norway and Yale Child Study Center
From this contributor
Journal Club: Meta-analysis oversells popular autism screen
The Modified Checklist for Autism in Toddlers (M-CHAT) accurately flags autistic toddlers, a new systematic review and meta-analysis suggests, contrary to past evidence that the tool’s validity varies depending on a child’s age and traits. Experts weigh in on the discrepancy.
Journal Club: Meta-analysis oversells popular autism screen
Reimagining autism screening: A conversation with Roald Øien
The questionnaires used to screen for autism are far from perfect, and tweaking them may not be enough. Roald Øien wants researchers to find better solutions.
Reimagining autism screening: A conversation with Roald Øien
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.